Anti-infective Waste in a Pediatric Institution: Pinpointing Problems in the Process.
| Autor: | MacBrayne, Christine E., Williams, Manon C., Obermeier, Haley, Child, Jason, Heizer, Justin W., Millard, Matt, Pearce, Kelly, Dugan, Casey, Parker, Sarah K. |
|---|---|
| Předmět: |
AMPHOTERICIN B
ANTI-infective agents ANTIFUNGAL agents CHILDREN'S hospitals COST control DRUG utilization DRUGS DRUG prescribing HOSPITAL costs INVENTORY shortages RESEARCH methodology MEDICAL wastes ARTIFICIAL membranes PHYSICIAN practice patterns DISCHARGE planning DESCRIPTIVE statistics MEROPENEM |
| Zdroj: | Hospital Pharmacy; Aug2020, Vol. 55 Issue 4, p220-223, 4p |
| Abstrakt: | Purpose: At Children's Hospital Colorado (CHCO), there are approximately 40 000 inpatient anti-infective orders every year resulting over 100 000 dispenses. Significant quantities of anti-infectives are wasted, incurring roughly $100 000 in waste annually. Identifying areas for improvement will result in cost savings and ameliorate the impact of drug shortages. Summary: This descriptive report discusses the reasons for anti-infective waste at a free-standing, quaternary-care, pediatric hospital. The anti-infectives with the highest cost in waste ($) included meropenem ($38 084), micafungin ($21 690), amphotericin B liposome ($15 913). An internal audit of CHCO anti-infective waste revealed that drugs are wasted for the following reasons: patient discharge, medication order discontinuation or change, and misplaced doses. Conclusion: The CHCO Antimicrobial Stewardship Program and the Pharmacy have proposed 4 process improvement measures that will target anti-infective waste to reduce pharmaceutical waste and hospital costs. These measures may be applicable to other drug classes that likely suffer from a similar proportion of waste. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|